<!DOCTYPE html>
<html>
<head>
    <title>In&#xAD;done&#xAD;sia grants emer&#xAD;gency ap&#xAD;proval for Si&#xAD;no&#xAD;vac vac&#xAD;cine - PressReader</title>
    <meta name="description" content="">
    <meta content="magazines, newspapers, digital news, reading, news, breaking news, newspaper online" name="keywords">
    <meta name="Robots" content="NOARCHIVE,NOODP">
    <meta charset="UTF-8">
    <meta http-equiv="Content-type" content="text/html; charset=utf-8" />
    <meta name="viewport" content="width=device-width, initial-scale=1" />
    
    <link rel="canonical" href="/singapore/the-straits-times/20210112/281797106632877" />

    <meta property="og:url" content="/singapore/the-straits-times/20210112/281797106632877">
    <meta property="og:type" content="article">
    <meta property="og:title" content="In&#xAD;done&#xAD;sia grants emer&#xAD;gency ap&#xAD;proval for Si&#xAD;no&#xAD;vac vac&#xAD;cine">
    <meta property="og:description" content="">
    <meta property="og:image" content="https://i.prcdn.co/img?regionKey=C7iHQdXwBU2H3yGwdr3POg%3d%3d" include-if="include-if">

    <meta name="twitter:url" content="/singapore/the-straits-times/20210112/281797106632877" />
    <meta name="twitter:card" content="summary" />
    <meta name="twitter:title" content="In&#xAD;done&#xAD;sia grants emer&#xAD;gency ap&#xAD;proval for Si&#xAD;no&#xAD;vac vac&#xAD;cine" />
    <meta name="twitter:description" content="" />
    <meta name="twitter:image" content="https://i.prcdn.co/img?regionKey=C7iHQdXwBU2H3yGwdr3POg%3d%3d" include-if="include-if"/>


    <style>
        li {
            margin: 1em 0;
        }
        img {
            max-width: 100%;
        }
        p, h1, h2, h3 {
            max-width: 100%;
        }

        .logo {
            display: inline-block;
            max-width: 100%;
            width: 100%;
            height:100px;
            text-indent: -10000px;
            overflow: hidden;
            background-image: url( https://r.prcdn.co/res//en-US/g3416/t0/2/images/pr-logo-new.svg );
            background-repeat: no-repeat;
            background-position: top left;
        }
        figure {
            border:0;
            padding: 0;
            margin: auto;
        }
    </style>
</head>
<body>
    <header>
        <p><a href="/" class="logo"><span>PressReader</span></a></p>
    </header>

    <nav>
        <ul>
            <li><a href="/catalog">Catalog</a></li>
            <li><a href="/">Home feed</a></li>
        </ul>
    </nav>

    

<article>

    <p><a href="/singapore/the-straits-times/textview" title="The Straits Times">The Straits Times</a></p>

    <h1>In&#xAD;done&#xAD;sia grants emer&#xAD;gency ap&#xAD;proval for Si&#xAD;no&#xAD;vac vac&#xAD;cine</h1>
    <h2></h2>
    <section>
        <time datetime="2021-01-12"><a href="/singapore/the-straits-times/20210112/textview" title="The Straits Times - 2021-01-12">2021-01-12</a></time> -
        Wahyudi So&#xAD;e&#xAD;ri&#xAD;aat&#xAD;madja In&#xAD;done&#xAD;sia Cor&#xAD;re&#xAD;spon&#xAD;dent In Jakarta wahyudis@sph.com.sg

            <a href="/category/tag-268435465/en/sg">Health</a> &middot;            <a href="/category/tag-268446479/en/sg">Pharmaceutical Industry</a> &middot;            <a href="/category/tag-268493114/en/sg">Medical Activism</a> &middot;            <a href="/category/tag-268489460/en/sg">Medicine</a> &middot;            <a href="/category/tag-268450473/en/sg">Infectious Diseases</a> &middot;            <a href="/category/tag-268450471/en/sg">Clinical Trials</a> &middot;            <a href="/category/tag-268491071/en/sg">Industries</a> &middot;            <a href="/category/tag-268489459/en/sg">Health Conditions</a> &middot;            <a href="/category/tag-268489471/en/sg">Pharmacology</a> &middot;            <a href="/category/tag-536891111/en/sg">Indonesia</a> &middot;            <a href="/category/tag-537068405/en/sg">Beijing</a> &middot;            <a href="/category/tag-538258087/en/sg">Sinovac Biotech</a> &middot;            <a href="/category/tag-537068074/en/sg">Asia</a> &middot;            <a href="/category/tag-537084687/en/sg">West Java</a> &middot;            <a href="/category/tag-537591445/en/sg">Java</a> &middot;            <a href="/category/tag-537074516/en/sg">World Health Organization</a> &middot;            <a href="/category/tag-537455997/en/sg">Andalusia</a> &middot;            <a href="/category/tag-536892803/en/sg">Pfizer</a> &middot;            <a href="/category/tag-536892359/en/sg">AstraZeneca</a> &middot;            <a href="/category/tag-537068102/en/sg">Brazil</a> &middot;            <a href="/category/tag-537068237/en/sg">Ukraine</a> &middot;            <a href="/category/tag-537068228/en/sg">Thailand</a> &middot;            <a href="/category/tag-536891206/en/sg">Singapore</a> &middot;            <a href="/category/tag-537068572/en/sg">Jakarta</a> &middot;            <a href="/category/tag-537068235/en/sg">Turkey</a> &middot;            <a href="/category/tag-538851418/en/sg">Joko Widodo</a> &middot;            <a href="/category/tag-537068569/en/sg">Bandung</a> &middot;            <a href="/category/tag-540357541/en/sg">Bio Farma</a>     </section>

        <p>The In­done­sian food and drug mon­i­tor­ing agency yes­ter­day is­sued emer­gency autho­ri­sa­tion for the coro­n­avirus vac­cine de­vel­oped by China’s Si­no­vac Biotech af­ter it was found to be 65.3 per cent ef­fec­tive in a lo­cal clin­i­cal trial.</p>
        <p>This paves the way for the world’s fourth most pop­u­lous coun­try – worst hit by the pan­demic in South-east Asia – to roll out its vac­ci­na­tion pro­gramme across its 34 prov­inces from Thurs­day.</p>
        <p>A trial of Coron­aVac in Ban­dung, the cap­i­tal of West Java prov­ince, re­vealed it had a 65.3 per cent ef­fi­cacy rate. “This is in line with the World Health Or­gan­i­sa­tion (re­quire­ment of) a min­i­mum ef­fi­cacy of 50 per cent,” said the head of drug mon­i­tor­ing agency BPOM, Dr Penny K. Luk­ito, in a vir­tual me­dia brief­ing.</p>
        <p>Dr Rizka An­dalu­cia, BPOM’s drug reg­is­tra­tion direc­tor, added: “The clin­i­cal trial still con­tin­ues, and if more data comes in, the ef­fi­cacy rate would be up­dated.”</p>
        <p>In­done­sia has re­ceived three mil­lion Coron­aVac doses and ex­pects 15 mil­lion more this week.</p>
        <p>It has also se­cured a to­tal of 100 mil­lion doses from Pfizer-BioNTech and As­traZeneca for de­liv­ery later this year.</p>
        <p>Other coun­tries plan­ning to use Si­no­vac’s vac­cine in­clude Brazil, Ukraine, Thai­land and Sin­ga­pore.</p>
        <p>In­done­sia’s phase three clin­i­cal trial – the last stage be­fore a vac­cine can be dis­trib­uted and given to the pub­lic – was con­ducted jointly by the Uni­ver­sity of Pad­jad­jaran in West Java prov­ince and vac­cine maker Bio Farma, and in­volved about 1,600 par­tic­i­pants. It started in mid-Au­gust last year.</p>
        <p>The trial had ear­lier been crit­i­cised as the uni­ver­sity did not work with other par­ties or higher ed­u­ca­tion in­sti­tutes, in­clud­ing those in Jakarta, which has the high­est preva­lence of the virus in the coun­try. The num­ber of trial par­tic­i­pants was also crit­i­cised for be­ing too small, dwarfed by the more than 10,000 vol­un­teers in Brazil’s tri­als and 7,000 in Turkey’s.</p>
        <p>Brazil had ear­lier an­nounced that its lo­cal tri­als found Coron­aVac to be 78 per cent ef­fec­tive, while Turkey said it was 91.25 per cent ef­fec­tive. Th­ese na­tions re­cruited most vol­un­teers from high­risk groups like med­i­cal work­ers, taxi driv­ers and min­i­mart cashiers.</p>
        <p>To­mor­row, Pres­i­dent Joko Wi­dodo and his Cabi­net mem­bers will be the first in the coun­try to re­ceive the vac­cine. Vac­ci­na­tion for med­i­cal work­ers and pub­lic of­fi­cials in all 34 prov­inces will start from Thurs­day.</p>
        <p>Three groups will re­ceive the shots in the ini­tial phase: high-rank­ing of­fi­cials, com­mit­tee mem­bers of med­i­cal work­ers’ as­so­ci­a­tions, and prom­i­nent med­i­cal doc­tors and re­li­gious lead­ers, Health min­is­ter Budi Gu­nadi Sadikin said last week.</p>
        <p>Dr Penny said the 65.3 per cent ef­fi­cacy rate meant the vac­cine is likely to re­duce the rate of in­fec­tions by about 65 per cent, which is “very mean­ing­ful”.</p>
        <p>She added that fur­ther mon­i­tor­ing will be con­ducted af­ter peo­ple re­ceive it, to find out its ef­fec­tive­ness out­side trial con­di­tions.</p>
        <p>“There will be a sep­a­rate mea­sure, the ef­fec­tive­ness rate, to re­flect the ef­fect of the vac­cine in the real population,” she told re­porters. “Ef­fi­cacy rate is from a clin­i­cal trial. It is an es­ti­mate.”</p>
        <p>In­done­sia yes­ter­day re­ported a to­tal of 836,718 cases of Covid-19, with 24,343 deaths.</p>

        <figure>
            <img src="https://i.prcdn.co/img?regionKey=C7iHQdXwBU2H3yGwdr3POg%3d%3d" alt=" ?? PHOTO: EPA-EFE ?? A med&#xAD;i&#xAD;cal worker ad&#xAD;min&#xAD;is&#xAD;ter&#xAD;ing a jab as part of a Covid-19 vac&#xAD;ci&#xAD;na&#xAD;tion drill yes&#xAD;ter&#xAD;day in Bali, In&#xAD;done&#xAD;sia."/>
            <figcaption>
                
                PHOTO: EPA-EFE
                A med&#xAD;i&#xAD;cal worker ad&#xAD;min&#xAD;is&#xAD;ter&#xAD;ing a jab as part of a Covid-19 vac&#xAD;ci&#xAD;na&#xAD;tion drill yes&#xAD;ter&#xAD;day in Bali, In&#xAD;done&#xAD;sia.
            </figcaption>
        </figure>

</article>

<section>
    <h3><a href="/catalog/language/english">Newspapers in English</a></h3>
    <h3><a href="/catalog/country/singapore">Newspapers from Singapore</a></h3>
</section>


    <footer>
        <p><a href="/" class="logo"><span>PressReader</span></a></p>
        <nav>
            <ul>
                    <li><a href="http://about.pressreader.com">Work with us</a></li>
                    <li><a href="https://about.pressreader.com/news/">Blog</a></li>
                    <li><a href="http://care.pressreader.com/hc/">Help center</a></li>
                    <li><a href="https://itunes.apple.com/app/pressreader/id313904711?amp%3Bmt=8&amp;mt=8">Download on the App Store</a></li>
                    <li><a href="https://play.google.com/store/apps/details?id=com.newspaperdirect.pressreader.android">Get it on App Store</a></li>
            </ul>
        </nav>
        <p><a href="https://care.pressreader.com/hc/en-us/articles/206528495-Terms-of-Use" target="_blank">Terms of Use</a> / <a href="https://care.pressreader.com/hc/en-us/articles/205818089-Privacy-Policy" target="_blank">Privacy Policy</a> / <a href="https://care.pressreader.com/hc/en-us/articles/360038010812-Privacy-Notice-for-California-Residents" target="_blank">CCPA</a></p>
        <p>© 2003-2020 PressReader</p>
    </footer>
    
        <script>
            (function (i, s, o, g, r, a, m) {
                i['GoogleAnalyticsObject'] = r; i[r] = i[r] || function () {
                    (i[r].q = i[r].q || []).push(arguments);
                }, i[r].l = 1 * new Date();
                a = s.createElement(o), m = s.getElementsByTagName(o)[0]; a.async = 1; a.src = g;
                m.parentNode.insertBefore(a, m);
            })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
        </script>
        <script>
        ga('create', 'UA-44408245-1');
        ga('send', 'pageView');
        </script>
</body>
</html>
